Utilizamos cookies para comprender de qué manera utiliza nuestro sitio y para mejorar su experiencia. Esto incluye personalizar el contenido y la publicidad. Para más información, Haga clic . Si continua usando nuestro sitio, consideraremos que acepta que utilicemos cookies.
NanoEnTek develops life science experiment equipment, medical in-vitro diagnostic devices, and related solutions. Its product portfolio includes automatic cell analyzers, white blood cell counters and point of care diagnostic devices.
FREND COVID-19 Neutralization Ab es una prueba de punto de atención (POCT) que se puede utilizar para comprobar si un paciente ha desarrollado la respuesta inmune al SARS-CoV-2 utilizando suero o plasma humano (EDTA).
The FREND COVID-19 Ag is a fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab specimens directly from individuals suspected with COVID-19 by their healthcare provider.
The FREND COVID-19 SP is a point-of-care test (POCT) which can be used to check whether patient has developed immune response to SARS-CoV-2 using human serum or plasma. The fluorescence immunoassay (FIA) uses the FREND System intended for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2. The test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
NanoEnTek develops life science experiment equipment, medical in-vitro diagnostic devices, and related solutions. Its product portfolio includes automatic cell analyzers, white blood cell counters and point of care diagnostic devices.
The FREND Cartridge TSH provides fast and accurate quantitative measurement of Thyroid-Stimulating Hormone (TSH) to assist physicians in managing patients with thyroid disorders. The disposable cartridge is designed for insertion into the FREND System, and enables fast and accurate quantitative in vitro diagnostic of the protein in human serum or plasma based on the lab-on-a-chip technology.
The FREND Vitamin D test is a fluorescent nanoparticle immunoassay designed for in vitro quantitative measurement of total 25-hydroxy (OH) Vitamin D. The disposable cartridge is designed for insertion into the FREND System and provides test results within three minutes from a 35μL sample.
The FREND Thyroid Duo cartridge measures the level of Thyroid-Stimulating Hormone (TSH) and Free T4 assisting physicians in managing patients with the thyroid disorders. The disposable cartridge is designed for insertion into the FREND System, and enables fast and accurate quantitative in vitro diagnostic of the protein in human serum or plasma based on the lab-on-a-chip technology.
The FREND Cartridge TSH provides fast and accurate quantitative measurement of Thyroid-Stimulating Hormone (TSH) to assist physicians in managing patients with thyroid disorders. The disposable cartridge is designed for insertion into the FREND System, and enables fast and accurate quantitative in vitro diagnostic of the protein in human serum or plasma based on the lab-on-a-chip technology.
The FREND Vitamin D test is a fluorescent nanoparticle immunoassay designed for in vitro quantitative measurement of total 25-hydroxy (OH) Vitamin D. The disposable cartridge is designed for insertion into the FREND System and provides test results within three minutes from a 35μL sample.
The FREND Thyroid Duo cartridge measures the level of Thyroid-Stimulating Hormone (TSH) and Free T4 assisting physicians in managing patients with the thyroid disorders. The disposable cartridge is designed for insertion into the FREND System, and enables fast and accurate quantitative in vitro diagnostic of the protein in human serum or plasma based on the lab-on-a-chip technology.
The FREND FLU A&B is a point-of-care test that detects Influenza A virus and Influenza B virus in human nasopharyngeal swab specimen. It runs on the FREND System using fluorescence immunoassay (FIA) technology and delivers accurate, fast results in three minutes.
The BioTracer Influenza A&B Rapid Card is a point-of-care test that easily detects Influenza type A and B infection in the respiratory organs. Using immunochromatography technology, the simple and user-friendly test delivers fast results within three minutes in just three steps.
BUDDI es un analizador de prueba de diagnóstico rápido y inteligente que evalúa las intensidades de la señal de línea en el dispositivo de prueba, lo que ayuda a aclarar la toma de decisiones y minimiza los posibles errores en los resultados.
The FREND COVID-19 SP is a point-of-care test (POCT) which can be used to check whether patient has developed immune response to SARS-CoV-2 using human serum or plasma. The fluorescence immunoassay (FIA) uses the FREND System intended for the qualitative detection of IgG and IgM antibodies to SARS-CoV-2. The test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.
The FREND COVID-19 Ag is a fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab specimens directly from individuals suspected with COVID-19 by their healthcare provider.
FREND COVID-19 Neutralization Ab es una prueba de punto de atención (POCT) que se puede utilizar para comprobar si un paciente ha desarrollado la respuesta inmune al SARS-CoV-2 utilizando suero o plasma humano (EDTA).
The FREND System is a rapid quantitative immunoassay analyzing instrument that utilizes disposable cartridges to provide in vitro diagnostics results. The compact, easy-to-use system uses innovative microchip technology and offers a flexible platform for multiple tests using a small sample volume for analysis.
The ADAMⅡ-CD34 is a bench top fluorescent cell counting analyzer that can capture a maximum of 136 images which are then processed by image analysis software integrated in the system. It features state-of-the-arts optics and can simultaneously analyze three color fluorescence samples using four-channel light sources.
El diseño del ADAM-rWBC permite contar el número de glóbulos blancos residuales en los productos sanguíneos leucoreducidos. Asegura el número de rWBCs, minimiza las complicaciones asociadas con las transfusiones, y también ofrece análisis automático de imágenes y detección sensible de la CCD.
